Evidence of gene deletion of p21 (WAFl/CIPi), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas
1996

Gene Deletion of p21 in Thyroid Carcinomas

Sample size: 57 publication Evidence: moderate

Author Information

Author(s): Y Shi, M Zou, NR Farid, ST Al-Sedairy

Primary Institution: King Faisal Specialist Hospital and Research Centre

Hypothesis

The study examines whether p21/Wafl gene deletion is involved in thyroid carcinogenesis.

Conclusion

The study found that p21/Wafl gene deletion is present in 12.5% of thyroid papillary carcinoma specimens and may play a significant role in thyroid cancer development.

Supporting Evidence

  • 12.5% of thyroid papillary carcinoma specimens had p21/Wafl gene deletions.
  • All deletions were found in the second exon of the p21/Wafl gene.
  • None of the samples with p21/Wafl deletions had p53 or Rb mutations.

Takeaway

Some thyroid cancers have a missing piece of a gene called p21, which helps control cell growth, and this might help the cancer grow.

Methodology

The study analyzed 57 thyroid tumor specimens for p21/Wafl gene deletions using RT-PCR and Southern blot analysis.

Limitations

The study did not find p21/Wafl deletions in benign adenomas, limiting the understanding of its role in non-cancerous conditions.

Participant Demographics

The study included 57 thyroid tumor specimens, consisting of 8 benign adenomas and 49 carcinomas.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication